These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
554 related articles for article (PubMed ID: 27465262)
1. (S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study. Höfler J; Rohracher A; Kalss G; Zimmermann G; Dobesberger J; Pilz G; Leitinger M; Kuchukhidze G; Butz K; Taylor A; Novak H; Trinka E CNS Drugs; 2016 Sep; 30(9):869-76. PubMed ID: 27465262 [TBL] [Abstract][Full Text] [Related]
2. Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit. Rohracher A; Höfler J; Kalss G; Leitinger M; Kuchukhidze G; Deak I; Dobesberger J; Novak H; Pilz G; Zerbs A; Trinka E Epilepsy Behav; 2015 Aug; 49():354-8. PubMed ID: 25962657 [TBL] [Abstract][Full Text] [Related]
3. [Effectiveness of ketamine in the treatment of refractory and super-refractory status epilepticus in children]. Wu J; Wang Q; Qian SY; Gao HM; Liu J; Deng J; Zeng JS Zhonghua Er Ke Za Zhi; 2020 Apr; 58(4):295-300. PubMed ID: 32234136 [No Abstract] [Full Text] [Related]
4. Ketamine reduces seizure and interictal continuum activity in refractory status epilepticus: a multicenter in-person and teleneurocritical care study. Harnicher B; Murray NM; Dresbach J; Collingridge DS; Reachi B; Bair J; Hoang Q; Fontaine GV Neurol Sci; 2024 Nov; 45(11):5449-5456. PubMed ID: 38862653 [TBL] [Abstract][Full Text] [Related]
5. Ketamine in the treatment of refractory and super-refractory status epilepticus: Experience from two centres. García-Ruiz M; Rodríguez PM; Palliotti L; Lastras C; Romeral-Jiménez M; Morales IG; Rey CP; Rodrigo-Gisbert M; Campos-Fernández D; Santamarina E; Carbonell BP Seizure; 2024 Apr; 117():13-19. PubMed ID: 38301485 [TBL] [Abstract][Full Text] [Related]
6. Propofol-ketamine combination therapy for effective control of super-refractory status epilepticus. Sabharwal V; Ramsay E; Martinez R; Shumate R; Khan F; Dave H; Iwuchukwu I; McGrade H Epilepsy Behav; 2015 Nov; 52(Pt A):264-6. PubMed ID: 26523340 [TBL] [Abstract][Full Text] [Related]
7. Mega-dose phenobarbital therapy for super-refractory status epilepticus. Byun JI; Chu K; Sunwoo JS; Moon J; Kim TJ; Lim JA; Jun JS; Lee HS; Lee WJ; Lee DY; Jeon D; Lee ST; Jung KH; Jung KY; Lee SK Epileptic Disord; 2015 Dec; 17(4):444-52. PubMed ID: 26575689 [TBL] [Abstract][Full Text] [Related]
8. Ketamine in adult super-refractory status epilepticus: Efficacy analysis on a prospective registry. Caranzano L; Novy J; Rossetti AO Acta Neurol Scand; 2022 Jun; 145(6):737-742. PubMed ID: 35274736 [TBL] [Abstract][Full Text] [Related]
9. Ketamine plus midazolam compared to midazolam infusion for the management of refractory status epilepticus. Fletman EW; Cleymaet S; Salvatore A; Devlin K; Pickard A; Shah SO Clin Neurol Neurosurg; 2024 Nov; 246():108592. PubMed ID: 39418930 [TBL] [Abstract][Full Text] [Related]
10. Stiripentol for the treatment of super-refractory status epilepticus. Strzelczyk A; Kortland LM; Knake S; Rosenow F Acta Neurol Scand; 2015 Dec; 132(6):435-9. PubMed ID: 25809474 [TBL] [Abstract][Full Text] [Related]
11. Ketamine for the treatment of refractory status epilepticus. Fang Y; Wang X Seizure; 2015 Aug; 30():14-20. PubMed ID: 26216679 [TBL] [Abstract][Full Text] [Related]
12. Ketamine continuous infusion for refractory status epilepticus in a patient with anticonvulsant hypersensitivity syndrome. Esaian D; Joset D; Lazarovits C; Dugan PC; Fridman D Ann Pharmacother; 2013 Nov; 47(11):1569-76. PubMed ID: 24259603 [TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study. Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834 [TBL] [Abstract][Full Text] [Related]
15. Factors associated with occurrence and outcome of super-refractory status epilepticus. Madžar D; Knappe RU; Reindl C; Giede-Jeppe A; Sprügel MI; Beuscher V; Gollwitzer S; Hamer HM; Huttner HB Seizure; 2017 Nov; 52():53-59. PubMed ID: 28963934 [TBL] [Abstract][Full Text] [Related]
16. Use of perampanel oral suspension for the treatment of refractory and super-refractory status epilepticus. Bruschi G; Pellegrino L; Bisogno AL; Ferreri F; Kassabian B; Seppi D; Favaretto S; Corbetta M; Dainese F Epilepsy Behav; 2024 Jul; 156():109826. PubMed ID: 38761446 [TBL] [Abstract][Full Text] [Related]
17. Secondary hypothermia in patients with super-refractory status epilepticus managed with propofol and ketamine. Sabharwal V; Poongkunran M; Talahma M; Iwuchukwu IO; Ramsay E; Khan F; Menon U; Ciccotto G; Khandker N; McGrade H Epilepsy Behav; 2020 Apr; 105():106960. PubMed ID: 32092461 [TBL] [Abstract][Full Text] [Related]
18. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. Holtkamp M; Othman J; Buchheim K; Meierkord H J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):534-9. PubMed ID: 15774441 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study. Sutter R; Marsch S; Rüegg S CNS Drugs; 2013 Apr; 27(4):321-9. PubMed ID: 23533010 [TBL] [Abstract][Full Text] [Related]
20. Status epilepticus: Refractory and super-refractory. Dubey D; Kalita J; Misra UK Neurol India; 2017; 65(Supplement):S12-S17. PubMed ID: 28281491 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]